Endostatin 33 Peptide Is a Deintegrin α6β1 Agent That Exerts Antitumor Activity by Inhibiting the PI3K-Akt Signaling Pathway in Prostate Cancer

HYD-PEP06 suppresses hepatocellular carcinoma metastasis, epithelial–mesenchymal transition and cancer stem cell-like properties by inhibiting PI3K/AKT and WNT/β-catenin signaling activation

(2021) Wei Tian et al.   Acta Pharmaceutica Sinica B

Androgen receptor-induced integrin α6β1 and Bnip3 promote survival and resistance to PI3K inhibitors in castration-resistant prostate cancer

(2020) Eric A. Nollet et al.   ONCOGENE

Role of αVβ3 in Prostate Cancer: Metastasis Initiator and Important Therapeutic Target

(2020) Lin Tang et al.   OncoTargets and Therapy

Thrombospondin‐2 stimulates MMP‐9 production and promotes osteosarcoma metastasis via the PLC, PKC, c‐Src and NF‐κB activation

(2020) Ju‐Fang Liu et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Cancer statistics, 2019

(2019) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

PEP06 polypeptide 30 is a novel cluster-dissociating agent inhibiting v integrin/FAK/Src signaling in oral squamous cell carcinoma cells

(2019) Gulnara Tuguzbaeva et al.   Acta Pharmaceutica Sinica B

Synthesis and biological evaluation of RGD conjugated with Ketoprofen/Naproxen and radiolabeled with [99mTc] via N4(GGAG) for αVβ3 integrin-targeted drug delivery

(2019) Reza Mohammadi et al.   DARU-Journal of Pharmaceutical Sciences

PEP06 polypeptide 30 exerts antitumour effect in colorectal carcinoma via inhibiting epithelial-mesenchymal transition

(2018) Siming Yu et al.   BRITISH JOURNAL OF PHARMACOLOGY

cRGD functionalised nanocarriers for targeted delivery of bioactives

(2018) K. R. Gajbhiye et al.   JOURNAL OF DRUG TARGETING

Recent advances on the progressive mechanism and therapy in castration-resistant prostate cancer

(2018) Keshan Wang et al.   OncoTargets and Therapy

Prostate cancer sheds the αvβ3 integrin in vivo through exosomes

(2018) Shiv Ram Krishn et al.   MATRIX BIOLOGY

αvβ3 INTEGRIN MEDIATES RADIORESISTANCE OF PROSTATE CANCER CELLS THROUGH REGULATION OF SURVIVIN

(2018) Tao Wang et al.   MOLECULAR CANCER RESEARCH

Tetraspanin 1 promotes epithelial-to-mesenchymal transition and metastasis of cholangiocarcinoma via PI3K/AKT signaling

(2018) Yan Wang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Exploring the Role of RGD-Recognizing Integrins in Cancer

(2017) Markus Nieberler et al.   Cancers

Lunasin suppresses the migration and invasion of breast cancer cells by inhibiting matrix metalloproteinase-2/-9 via the FAK/Akt/ERK and NF-κB signaling pathways

(2016) QIANQIAN JIANG et al.   ONCOLOGY REPORTS

Risk Stratification in Hormone-sensitive Metastatic Prostate Cancer: More Questions than Answers

(2015) Sarah P. Psutka et al.   EUROPEAN UROLOGY

Glycosylation of the laminin receptor (α3β1) regulates its association with tetraspanin CD151: Impact on cell spreading, motility, degradation and invasion of basement membrane by tumor cells

(2014) Amit Ranjan et al.   EXPERIMENTAL CELL RESEARCH

The Androgen Receptor Induces Integrin  6 1 to Promote Prostate Tumor Cell Survival via NF- B and Bcl-xL Independently of PI3K Signaling

(2011) L. E. Lamb et al.   CANCER RESEARCH

The laminin binding integrin α6β1 in prostate cancer perineural invasion

(2010) Isis C. Sroka et al.   JOURNAL OF CELLULAR PHYSIOLOGY

MMP-2 alters VEGF expression via αVβ3 integrin-mediated PI3K/AKT signaling in A549 lung cancer cells

(2009) Chandramu Chetty et al.   INTERNATIONAL JOURNAL OF CANCER